Markets:

Overview

News

Currencies

International

Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

92.77 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

59 60 Next >

AZN Stock Under Pressure ↗

January 23, 2023

Shares in UK-headquartered AstraZeneca are back under heavy selling pressure on Monday as the stock extends recent losses.

Via Talk Markets

The Top Healthcare Stocks to Buy With $100 ↗

January 23, 2023

Don't overlook these big-name foreign healthcare stocks.

Via The Motley Fool

Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market ↗

January 19, 2023

After years of lab failures, the companies could crack open a multibillion-dollar market.

Via Investor's Business Daily

AstraZeneca’s Next “Wonder Drug” ↗

January 19, 2023

Enhertu is an antibody-drug conjugate, a type of therapy designed to do minimal damage to healthy, non-cancerous cells. Wall Street analysts believe that Enhertu has the potential to become a key...

Via Talk Markets

Week In Review: Qitan Raises $101 Million For Nanopore Sequencing Devices ↗

January 14, 2023

Qitan Technology, a Chengdu nanopore sequencing company, completed a $101 million Series C round to support its commercialized nanopore devices. Meanwhile, Japan’s Takeda was approved to launch...

Via Talk Markets

The Viral “Tripledemic” Opportunity ↗

January 14, 2023

Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu...

Via Talk Markets

Why Shares of Compugen Rose on Thursday ↗

December 29, 2022

The clinical-stage biotech retreated a bit from one of its biggest days in a while.

Via The Motley Fool

This Favorable Sign Appears On AstraZeneca's Chart ↗

December 28, 2022

Via Benzinga

3 Growth Stocks Poised for Huge Gains in 2023 ↗

January 14, 2023

These big pharmaceuticals are poised for back-to-back big years.

Via The Motley Fool

Why These Two Biotech Stocks Blasted Higher This Week ↗

January 13, 2023

There's nothing like a big-premium buyout to send a company's share price to the moon.

Via The Motley Fool

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗

January 13, 2023

Sharp Tesla price cuts and some notable earnings were in focus.

Via Investor's Business Daily

Could This New Drug Launch Be a Hit for Viatris? ↗

January 12, 2023

Viatris and Kindeva Drug Delivery could soon launch a generic version of AstraZeneca's Symbicort.

Via The Motley Fool

AstraZeneca's New Asthma Treatment for Adults Gets Green Light from FDA ↗

January 11, 2023

Via Benzinga

AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout ↗

January 10, 2023

CinCor will bolster AstraZeneca's growing cardio-renal business.

Via Investor's Business Daily

AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal ↗

January 09, 2023

AstraZeneca stock wavered as it agreed to buy CinCor Pharma, maker of blood pressure drug baxdrostat for $1.8 billion. CINC stock soared.

Via Investor's Business Daily

Why Is CinCor (CINC) Stock Up 138% Today? ↗

January 09, 2023

CinCor (CINC) stock is rocketing higher on Monday following news that AstraZeneca (AZN) is acquiring the company for up to $1.8 billion.

Via InvestorPlace

Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories ↗

January 09, 2023

Bloomberg

Via Benzinga

AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline ↗

January 09, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 09, 2023

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

1 Stock Defying the Downturn to Buy, and 1 to Avoid ↗

January 06, 2023

These two stocks might go in different directions in the future.

Via The Motley Fool

CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗

January 06, 2023

Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.

Via Investor's Business Daily

AstraZeneca's Current Valuation Not Reflective Of Its Strong Fundamentals, Analyst Says ↗

January 05, 2023

Via Benzinga

AstraZeneca Stock Scores Relative Strength Rating Upgrade ↗

January 04, 2023

AstraZeneca ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

What Does AstraZeneca's Debt Look Like? ↗

January 04, 2023

Shares of AstraZeneca Inc. (NASDAQ:AZN) moved higher by 28.78% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...

Via Benzinga

3 Top Healthcare Stocks Defying the Bear Market ↗

January 03, 2023

These healthcare companies look poised to continue their runs.

Via The Motley Fool

Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study ↗

January 03, 2023

Via Benzinga

Got $1,000? 5 Sensational Stocks to Buy to Start 2023 With a Bang ↗

December 26, 2022

You don't need a mountain of money to grow your wealth on Wall Street.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

2 Market-Beating Stocks to Buy in 2023 and Hold Forever ↗

December 24, 2022

For these companies' shareholders, it may be tempting to take profits right now. But both stocks can keep growing for a while.

Via The Motley Fool

The Top Healthcare Stocks to Buy With $100 ↗

December 22, 2022

Healthcare is a sector that has proven to be reliable in recessions.

Via The Motley Fool

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

59 60 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

Headline News about AstraZeneca PLC - American Depositary Shares

Starting at $3.75/week.

Subscribe Today